These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 6052899)

  • 1. A double-blind evaluation of an anorexiant, a placebo and diet alone in obese subjects.
    Resnick M; Joubert L
    Can Med Assoc J; 1967 Oct; 97(17):1011-5. PubMed ID: 6052899
    [No Abstract]   [Full Text] [Related]  

  • 2. Double-blind clinical evaluation of mazindol, dextroamphetamine, and placebo in treatment of exogenous obesity.
    Defelice EA; Chaykin LB; Cohen A
    Curr Ther Res Clin Exp; 1973 Jul; 15(7):358-66. PubMed ID: 4198296
    [No Abstract]   [Full Text] [Related]  

  • 3. Double-blind trial of anorectic agents.
    Sproule BC
    Med J Aust; 1969 Feb; 1(8):394-5. PubMed ID: 4889477
    [No Abstract]   [Full Text] [Related]  

  • 4. A new anorexiant. Clinical evaluation.
    Smith DE
    Rocky Mt Med J; 1974 Jan; 71(1):41-4. PubMed ID: 4131377
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of phentermine-amphetamine resin complex with sustained-release dextroamphetamine and placebo in the treatment of exogenous obesity.
    De Felice EA; Cohen A; Schmitz PL; Rothwell KG; Truant AP
    J Clin Pharmacol J New Drugs; 1968; 8(6):360-9. PubMed ID: 4883784
    [No Abstract]   [Full Text] [Related]  

  • 6. Double-blind comparison of placebo and 42-548, a new appetite suppressant, in obese volunteers.
    De Felice EA; Bronstein S; Cohen A
    Curr Ther Res Clin Exp; 1969 May; 11(5):256-62. PubMed ID: 4977396
    [No Abstract]   [Full Text] [Related]  

  • 7. A clinical trial of fenfluramine.
    Traherne JB
    Practitioner; 1965 Nov; 195(169):677-80. PubMed ID: 5321366
    [No Abstract]   [Full Text] [Related]  

  • 8. Phentermine resin as an adjunct in medical weight reduction: a controlled, randomized, double-blind prospective study.
    Truant AP; Olon LP; Cobb S
    Curr Ther Res Clin Exp; 1972 Nov; 14(11):726-38. PubMed ID: 4629111
    [No Abstract]   [Full Text] [Related]  

  • 9. [Phentermine resinate in obesity. Clinical trial of Mirapront in adipose children].
    Spranger J
    Munch Med Wochenschr; 1965 Sep; 107(38):1833-4. PubMed ID: 5323498
    [No Abstract]   [Full Text] [Related]  

  • 10. A controlled study of the effects of group discussions and an anorexiant in outpatient treatment of obesity. With attention to the psychological aspects of dieting.
    London AM; Schreiber ED
    Ann Intern Med; 1966 Jul; 65(1):80-92. PubMed ID: 5327947
    [No Abstract]   [Full Text] [Related]  

  • 11. [Long-term treatment of patients with obesity using mazindol and a reducing diet].
    van Seters AP; Bouwhuis-Hoogerwerf ML; Goslings BM; van Nieuwkoop L; van Slooten H; Struijk-Wielinga T
    Ned Tijdschr Geneeskd; 1982 May; 126(22):990-4. PubMed ID: 7110390
    [No Abstract]   [Full Text] [Related]  

  • 12. TDrug therapy in obesity.
    Ruedy J
    Mod Treat; 1967 Nov; 4(6):1138-45. PubMed ID: 6080141
    [No Abstract]   [Full Text] [Related]  

  • 13. [The importance of the biguanides in the treatment of obesity].
    Bittnerová H; Masek J; Rath R
    Z Gesamte Inn Med; 1969 Mar; 24(5):139-42. PubMed ID: 5785830
    [No Abstract]   [Full Text] [Related]  

  • 14. Preliminary clinical evaluation of a new appetite suppressant. A double-blind study.
    Feldman HS
    J Med Soc N J; 1966 Oct; 63(10):454-7. PubMed ID: 5341753
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of an anorexic drug in a total weight reduction program in private practice.
    Nolan GR
    Curr Ther Res Clin Exp; 1975 Aug; 18(2):332-7. PubMed ID: 809245
    [No Abstract]   [Full Text] [Related]  

  • 16. Double-blind comparison of efficacy, safety, and side effects of Bionamin, phentermine compound, and placebo in the treatment of exogenous obesity.
    Cohen A; De Felice EA; Leb SM; Fuentes JG; Rothwell KG; Truant AP
    Curr Ther Res Clin Exp; 1968 Jul; 10(7):323-34. PubMed ID: 4969672
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term maintenance of weight loss with sibutramine in a GP setting following a specialist guided very-low-calorie diet: a double-blind, placebo-controlled, parallel group study.
    Mathus-Vliegen EM;
    Eur J Clin Nutr; 2005 Aug; 59 Suppl 1():S31-8; discussion S39. PubMed ID: 16052193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical study of a current anorexigenic agent: T.D].
    Plauchu M; Paffoy JC; Philippe LP; Nove-Josserand G; Chollet A; Valancogne C
    Lyon Med; 1972 Oct; 228(15):291-4. PubMed ID: 4639053
    [No Abstract]   [Full Text] [Related]  

  • 19. Obesity-depression: clinical evaluation with a new anorexigenic agent.
    Kornhaber A
    Psychosomatics; 1973; 14(3):162-7. PubMed ID: 4604838
    [No Abstract]   [Full Text] [Related]  

  • 20. Controlled clinical evaluation of a new anorectic agent in obese adults.
    Elmaleh MK; Miller J
    Pa Med; 1974 Sep; 77(9):46-50. PubMed ID: 4609056
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.